• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Singular Genomics Systems downgraded by BofA Securities with a new price target

    8/10/22 6:30:40 AM ET
    $OMIC
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $OMIC alert in real time by email
    BofA Securities downgraded Singular Genomics Systems from Buy to Underperform and set a new price target of $3.00
    Get the next $OMIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OMIC

    DatePrice TargetRatingAnalyst
    8/17/2022$10.00 → $4.50Buy → Neutral
    UBS
    8/10/2022$3.50Buy → Neutral
    Goldman
    8/10/2022$3.00Buy → Underperform
    BofA Securities
    1/7/2022$21.00Neutral → Buy
    BofA Securities
    10/15/2021Outperform
    Cowen
    More analyst ratings

    $OMIC
    SEC Filings

    See more
    • Singular Genomics Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant

      8-K - Singular Genomics Systems, Inc. (0001850906) (Filer)

      2/27/25 1:42:39 PM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.

      SCHEDULE 13D/A - Singular Genomics Systems, Inc. (0001850906) (Subject)

      2/25/25 9:18:06 PM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form EFFECT filed by Singular Genomics Systems Inc.

      EFFECT - Singular Genomics Systems, Inc. (0001850906) (Filer)

      2/24/25 12:15:05 AM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $OMIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)

      4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)

      2/27/25 8:54:47 PM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)

      2/25/25 8:12:58 PM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Singular Genomics Systems, Inc. (0001850906) (Issuer)

      2/25/25 8:11:40 PM ET
      $OMIC
      Biotechnology: Laboratory Analytical Instruments
      Industrials